APA (7th ed.) Citation

SE, P., S, D., RL, S., K, H., PW, I., & AH, D. (2013). Human carboxylesterase-2 hydrolyzes the prodrug of gemcitabine (LY2334737) and confers prodrug sensitivity to cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 19(5), 1159. https://doi.org/10.1158/1078-0432.CCR-12-1184

Chicago Style (17th ed.) Citation

SE, Pratt, Durland-Busbice S, Shepard RL, Heinz-Taheny K, Iversen PW, and Dantzig AH. "Human Carboxylesterase-2 Hydrolyzes the Prodrug of Gemcitabine (LY2334737) and Confers Prodrug Sensitivity to Cancer Cells." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 19, no. 5 (2013): 1159. https://doi.org/10.1158/1078-0432.CCR-12-1184.

MLA (9th ed.) Citation

SE, Pratt, et al. "Human Carboxylesterase-2 Hydrolyzes the Prodrug of Gemcitabine (LY2334737) and Confers Prodrug Sensitivity to Cancer Cells." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 19, no. 5, 2013, p. 1159, https://doi.org/10.1158/1078-0432.CCR-12-1184.